NTRK fusion detection across multiple assays and 33,997 cases: diagnostic implications and pitfalls
出版年份 2019 全文链接
标题
NTRK fusion detection across multiple assays and 33,997 cases: diagnostic implications and pitfalls
作者
关键词
-
出版物
MODERN PATHOLOGY
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2019-08-03
DOI
10.1038/s41379-019-0324-7
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Colorectal carcinomas containing hypermethylated MLH1 promoter and wild type BRAF/KRAS are enriched for targetable kinase fusions
- (2019) Emiliano Cocco et al. CANCER RESEARCH
- High yield of RNA sequencing for targetable kinase fusions in lung adenocarcinomas with no driver alteration detected by DNA sequencing and low tumor mutation burden
- (2019) Ryma Benayed et al. CLINICAL CANCER RESEARCH
- Pan-Trk Immunohistochemistry Identifies NTRK Rearrangements in Pediatric Mesenchymal Tumors
- (2018) Erin R. Rudzinski et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Primary and Metastatic Melanoma With NTRK Fusions
- (2018) Cecilia Lezcano et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- NTRK Fusions Define a Novel Uterine Sarcoma Subtype With Features of Fibrosarcoma
- (2018) Sarah Chiang et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Emerging Targeted Therapy for Tumors with NTRK Fusion Proteins
- (2018) Ed S. Kheder et al. CLINICAL CANCER RESEARCH
- Targetable Gene Fusions Associate With the IDH Wild-Type Astrocytic Lineage in Adult Gliomas
- (2018) Sherise D Ferguson et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- Efficacy of Larotrectinib in TRK Fusion–Positive Cancers in Adults and Children
- (2018) Alexander Drilon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Gene Fusion in Malignant Glioma: An Emerging Target for Next-Generation Personalized Treatment
- (2018) Tao Xu et al. Translational Oncology
- Molecular characterization of cancers with NTRK gene fusions
- (2018) Zoran Gatalica et al. MODERN PATHOLOGY
- NTRK fusion-positive cancers and TRK inhibitor therapy
- (2018) Emiliano Cocco et al. Nature Reviews Clinical Oncology
- Identification of NTRK3 Fusions in Childhood Melanocytic Neoplasms
- (2017) Lu Wang et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- ALK, ROS1, and NTRK Rearrangements in Metastatic Colorectal Cancer
- (2017) Filippo Pietrantonio et al. JNCI-Journal of the National Cancer Institute
- Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients
- (2017) Ahmet Zehir et al. NATURE MEDICINE
- Safety and Antitumor Activity of the Multitargeted Pan-TRK, ROS1, and ALK Inhibitor Entrectinib: Combined Results from Two Phase I Trials (ALKA-372-001 and STARTRK-1)
- (2017) Alexander Drilon et al. Cancer Discovery
- ALK, ROS1, and NTRK Rearrangements in Metastatic Colorectal Cancer
- (2017) Filippo Pietrantonio et al. JNCI-Journal of the National Cancer Institute
- ETV6-NTRK3 Is Expressed in a Subset of ALK-Negative Inflammatory Myofibroblastic Tumors
- (2016) Ali H. Alassiri et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Review and Updates of Immunohistochemistry in Selected Salivary Gland and Head and Neck Tumors
- (2015) Shaobo Zhu et al. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
- Anchored multiplex PCR for targeted next-generation sequencing
- (2014) Zongli Zheng et al. NATURE MEDICINE
- TRKing Down an Old Oncogene in a New Era of Targeted Therapy
- (2014) Aria Vaishnavi et al. Cancer Discovery
- ETV6-NTRK3 is a common chromosomal rearrangement in radiation-associated thyroid cancer
- (2013) Rebecca J. Leeman-Neill et al. CANCER
- Identification of kinase fusion oncogenes in post-Chernobyl radiation-induced thyroid cancers
- (2013) Julio C. Ricarte-Filho et al. JOURNAL OF CLINICAL INVESTIGATION
- Secretory Breast Carcinoma: Unique, Triple-Negative Carcinoma With a Favorable Prognosis and Characteristic Molecular Expression
- (2011) Pooja Vasudev et al. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
- Rearrangements of NTRK1 gene in papillary thyroid carcinoma
- (2009) A. Greco et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started